See McLaughlin et al [2013] for consensus document, including Reassessing Patients Over Time.

The clinical course of HPAH is highly variable, ranging from rapid progression to long periods of stable clinical status. The appropriate surveillance measures and timing are determined by the relative stability of the patient's clinical condition. Patients who are declining should be in frequent contact with their health care providers so that therapies may be changed or added.
